Business
Kimberly-Clark Pushes Kenvue Note Exchange Deadline to November 2 After $4.56 Billion Tendered
By News Desk ·
Key takeaways
- Kimberly-Clark extended the expiration date of its exchange offers for Kenvue notes from October 27 to November 2, 2026.
- Holders had tendered $4.56 billion of the $7 billion aggregate principal amount as of the original deadline.
- The 5.050% notes due 2053 drew the highest tender rate at 98.54% of their outstanding principal amount.
Kimberly-Clark extended the expiration date of its offers to exchange Kenvue notes for up to $7 billion of new Kimberly-Clark notes from October 27 to November 2, 2026, the company said in a PR Newswire release. Holders had tendered $4.56 billion of the $7 billion aggregate principal amount as of the original deadline.
Kimberly-Clark's Exchange Offer and Tender Totals
Kimberly-Clark, the Irving-based maker of Huggies, Kleenex and Kotex, is offering to swap any and all outstanding Kenvue notes for new notes it issues. The offers cover seven series of Kenvue notes with $7 billion in aggregate principal outstanding. As of 5:00 p.m. New York City time on October 27, 2026, the tendered amounts ranged from $739.3 million of the 5.050% senior notes due 2028, or 73.93% of that series, to $1.5 billion of the 5.050% senior notes due 2053, or 98.54%. The 5.000% notes due 2030 drew $846.5 million, or 84.65%, and the 4.850% notes due 2032 drew $702.7 million, or 93.69%. The 4.900% notes due 2033 drew $1.2 billion, or 92.21%; the 5.100% notes due 2043 drew $728.4 million, or 97.12%; and the 5.200% notes due 2063 drew $726.3 million, or 96.84%.
The exchange offers are conditioned on Kimberly-Clark completing its pending acquisition of Kenvue, a condition the company said it may not waive. Kimberly-Clark said it expects settlement to occur promptly after the expiration date. On the early participation date of October 9, 2026, requisite consents were received for amendments to the indenture governing the Kenvue notes, and a supplemental indenture containing the amendments was executed. The amendments become operative only upon settlement of the exchange offers.
Kimberly-Clark's Pending Kenvue Acquisition
According to akta.pro company records, Kimberly-Clark has a pending $48.7 billion acquisition of Kenvue. The same records describe the transaction as creating a combined consumer health and wellness company with approximately $31.6-32 billion in annual net sales, expected to close in the second half of 2026 pending regulatory approvals. Kimberly-Clark reported $16.4 billion in revenue for fiscal 2025, down from $16.8 billion the prior year, and net income of approximately $2.0 billion.
Earlier Kimberly-Clark Leadership and Dividend News
Kimberly-Clark announced executive departures and leadership changes ahead of the Kenvue acquisition in the fourth quarter, PRESSBEE reported on October 15, 2026. President and COO Russ Torres will leave to become CEO of another company and remain with the firm. On October 13, 2026, 247wallst reported that Kimberly-Clark paid its third straight $1.28 quarterly dividend, extending a 54-year streak, while 2025 free cash flow covered the $1.66 billion payout at 101%.
What Comes Next for the Kenvue Notes
The extended expiration date is 5:00 p.m. New York City time on November 2, 2026, and Kimberly-Clark said the date may be further extended. The company said all other terms of the exchange offers remain unchanged.